Ascendis Pharma A (ASND) EBIT Margin Growth (1y) (2015 - 2026)
Ascendis Pharma A (ASND) EBIT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ascendis Pharma A |
2.75 Bn |
2.08 Bn |
268.20 Mn |
11,329.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
11,329.00 |
| Dec 31, 2025 |
-15.17 Mn |
| Sep 30, 2025 |
17,243.00 |
| Jun 30, 2025 |
33,668.00 |
| Mar 31, 2025 |
-5,198.00 |
| Dec 31, 2024 |
15.17 Mn |
| Sep 30, 2024 |
11,254.00 |
| Jun 30, 2024 |
-7,301.00 |
| Mar 31, 2024 |
37,652.00 |
| Dec 31, 2023 |
62,869.00 |
| Sep 30, 2023 |
66,528.00 |
| Jun 30, 2023 |
200,629.00 |
| Mar 31, 2023 |
144,728.00 |
| Dec 31, 2022 |
-49,863.00 |
| Sep 30, 2022 |
776,398.00 |
| Jun 30, 2022 |
920,623.00 |
| Mar 31, 2022 |
1.48 Mn |
| Dec 31, 2021 |
568.00 |
| Sep 30, 2021 |
-584,999.00 |
| Jun 30, 2021 |
-573,343.00 |
